FDA Inspection
Chunghwa Chemical Synthesis & Biotech Co., LtdChunghwa Chemical Synthesis & Biotech Co., Ltd – FDA Inspection, Nov 9, 2018
Record Details
This FDA Inspection record concerns Chunghwa Chemical Synthesis & Biotech Co., Ltd, with an inspection on November 9, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 9, 2018
- Product Type
- Drugs
View Company Profile
ID · 5912c1cf-d6c4-457c-ab1e-f4aba74580f7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1073483
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Chunghwa Chemical Synthesis & Biotech Co., Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 12, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 29, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 20, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chunghwa Chemical Synthesis & Biotech Co., Ltd
- FDA Inspection 1241802 - 2024-04-12
- FDA Inspection 1192138 - 2022-11-18
- FDA Inspection 1151870 - 2021-06-21
- FDA Inspection 1013091 - 2017-03-29
- FDA Inspection 881707 - 2014-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.